HSP90B1 and neoplasm: Pioneering studies by Srivastava and colleagues first demonstrated tumor-specific antigenicity to Gp96, Hsp70, and Hsp90, a function associated with their ability to chaperone antigenic peptides and to activate antitumor cytotoxic T lymphocyte (CTL) responses (3, 4, 15).